Drug Safety Update

Volume 1, Issue 12 July 2008

Latest advice for medicines users

Patient Information Leaflet of the month: Aldactone

Article date: July 2008

Patient information leaflets (PILs) are improving in quality as a result of new legal obligations on manufacturers to test the documents on potential patients. Testing makes sure that the presentation of the information enables patients to find and understand key messages for safe use about the medicine within the PIL and thereby enable them to use the medicine safely and effectively. To promote this new initiative, we are publishing a series of examples of best practice on our website. The latest in the series is the PIL for Aldactone (spironolactone), a diuretic for treatment of congestive heart failure and for oedema and ascites caused by cirrhosis of the liver.

Access PIL of the month here


Article citation: Drug Safety Update Jul 2008; Vol 1, Issue 12: 11


Search tips and FAQs
  • Looking for previous DSU publications?

    Search by publication date above or view earlier publications in PDF
Page last modified: 31 August 2010